ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,759Medicare Part D Prescriptions Filled, Including Refills

Rank: 94 out of 1448

$1.01M Total Retail Price of All Prescriptions

Rank: 26 out of 1448

765 Patients Receiving at Least One Drug in Part D
72%Patients 65 Years and Older
61% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

3% of this provider’s 765 patients filled at least one prescription for a schedule three drug, compared to an average of 2%.

Risky Drugs to Seniors

0% of this provider’s 6,493 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

48% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$115 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

11 is the average number of prescriptions (including refills) per patient, compared to an average of 12.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
AMLODIPINE BESYLATE 569 463 1 2
CARVEDILOL 510 424 2 1
CRESTOR 507 378 3 17
RANEXA 472 316 4 37
ATORVASTATIN CALCIUM 342 259 5 4
DIOVAN 332 228 6 15
LOVAZA 324 224 7 39
FUROSEMIDE 275 186 8 7
LOSARTAN POTASSIUM 271 233 9 11
HYDROCHLOROTHIAZIDE 266 196 10 18
WARFARIN SODIUM 265 190 11 8
AMIODARONE HCL 248 204 12 22
BYSTOLIC 231 175 13 32
METOPROLOL TARTRATE 189 133 14 9
SIMVASTATIN 180 147 15 3
LISINOPRIL 176 92 16 5
CLOPIDOGREL 176 135 16 10
FENOFIBRATE 151 84 18 54
PLAVIX 141 112 19 14
METOPROLOL SUCCINATE 136 92 20 6
ZETIA 135 108 21 28
POTASSIUM CHLORIDE 134 102 22 19
EXFORGE 128 100 23 80
ISOSORBIDE MONONITRATE ER 126 94 24 16
BENICAR 122 89 25 50
LIPITOR 119 71 26 30
TRILIPIX 103 69 27 86
MULTAQ 97 97 28 57
DIOVAN HCT 83 61 29 29
PRAVASTATIN SODIUM 77 63 30 20
PRADAXA 76 59 31 27
EXFORGE HCT 73 41 32 172
LOVASTATIN 68 59 33 35
OMEPRAZOLE 64 41 34 23
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 20, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.